0000891293-17-000105.txt : 20171003 0000891293-17-000105.hdr.sgml : 20171003 20171003151638 ACCESSION NUMBER: 0000891293-17-000105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170929 FILED AS OF DATE: 20171003 DATE AS OF CHANGE: 20171003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SINGER JACK W CENTRAL INDEX KEY: 0001204264 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28386 FILM NUMBER: 171117474 MAIL ADDRESS: STREET 1: 501 ELLIOT AVENUE WEST STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-09-29 0 0000891293 CTI BIOPHARMA CORP ctic 0001204264 SINGER JACK W 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 0 1 0 0 EVP, Chief Scientific Officer Non-Qualified Stock Option (right to buy) 3.19 2017-09-29 4 A 0 115000 0 A 2027-09-29 Common Stock 115000 115000 D The stock option will vest in six equal semi-annual installments over a three-year period beginning September 29, 2017 subject to continued employment by CTIC through the applicable vesting dates. Jack W. Singer 2017-10-03